GS Malhi, D Bassett, P Boyce… - Australian & New …, 2015 - journals.sagepub.com
Objectives: To provide guidance for the management of mood disorders, based on scientific evidence supplemented by expert clinical consensus and formulate recommendations to …
The Canadian Network for Mood and Anxiety Treatments (CANMAT) previously published treatment guidelines for bipolar disorder in 2005, along with international commentaries and …
MA Katzman, P Bleau, P Blier, P Chokka, K Kjernisted… - BMC psychiatry, 2014 - Springer
Background Anxiety and related disorders are among the most common mental disorders, with lifetime prevalence reportedly as high as 31%. Unfortunately, anxiety disorders are …
L Plans, C Barrot, E Nieto, J Rios, TG Schulze… - Journal of affective …, 2019 - Elsevier
Background Completed suicide is a major cause of death in bipolar disorder (BD) patients. Objective The aim of this paper is to provide an overall review of the existing literature of …
Background: The current paper introduces the actual International College of Neuro- Psychopharmacology clinical guidelines for the treatment of bipolar disorder. Concept and …
Background Conventional meta-analyses have shown inconsistent results for efficacy of pharmacological treatments for acute mania. We did a multiple-treatments meta-analysis …
GS Malhi, M Tanious, P Das, CM Coulston, M Berk - CNS drugs, 2013 - Springer
Lithium has been used for over half a century for the treatment of bipolar disorder as the archetypal mood stabilizer, and has a wealth of empirical evidence supporting its efficacy in …
Objectives. These guidelines are based on a first edition that was published in 2004, and have been edited and updated with the available scientific evidence up to October 2012 …